+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Microorganism Feed Carbohydrase Global Market Report 2024 - Product Thumbnail Image

Microorganism Feed Carbohydrase Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Alpha Glucosidase Inhibitors Global Market Report 2024 - Product Thumbnail Image

Alpha Glucosidase Inhibitors Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Human Insulin Drugs Market in Brazil 2024-2028 - Product Thumbnail Image

Human Insulin Drugs Market in Brazil 2024-2028

  • Report
  • December 2023
  • 142 Pages
  • Brazil
From
From
From
From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Disposable Syringes Global Market Report 2024 - Product Thumbnail Image

Disposable Syringes Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
Injection Pen Global Market Report 2024 - Product Thumbnail Image

Injection Pen Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Loading Indicator